XML 22 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
Common Stock
6 Months Ended
Jun. 30, 2017
Stockholders' Equity Note [Abstract]  
Common Stock
Common Stock
 
The Company’s common stock has the following characteristics:

The holders of shares of common stock are entitled to one vote for each share of common stock held at all meetings of stockholders. 
The holders of shares of common stock are entitled to receive dividends, if and when declared by the Company’s board of directors. Since inception, no cash dividends have been declared.
 
Offerings
 
In September 2015, the Company and the Cancer Prevention and Research Institute of Texas (“CPRIT”) entered into a grant contract, effective as of June 1, 2014 (the "2014 Contract"), in connection with an award of approximately $16.8 million. The award was in the form of an agreement by CPRIT to purchase $16.8 million of shares of common stock of the Company in a private placement concurrent with the initial public offering of the Company’s common stock. On October 5, 2015, CPRIT purchased 2,395,010 shares of the Company’s common stock at $7.00 per share.  Net proceeds from the private placement, after related transaction offering costs, were approximately $16.6 million
 
In October 2015, the Company issued 6.25 million shares of common stock in an underwritten public offering, with a price of $7.00 per share.  The underwriters purchased an additional 704,962 shares of the Company's common stock pursuant to their option to purchase additional shares.  The Company received aggregate net proceeds of approximately $43.7 million in the public offering, after deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company.